Literature DB >> 216931

Solubilization of a mammalian beta-adrenergic receptor.

J Kleinstein, H Glossmann, L Braun, C Konrad.   

Abstract

Binding sites for iodohydroxybenzylpindolol with characteristics of a beta2-adrenergic receptor have been identified in a crude membrane fraction from guinea-pig lung. The binding sites could be solubilized by treatment of the membrane fraction with digitonin. Upon solubilization receptors retain their beta2-adrenergic type as indicated by the rank order of potencies of agonists in binding-inhibition experiments. The solubilized receptors demonstrate a marked increase in affinity for agonists compared with particulate receptors whereas antagonist affinity remains unchanged. Solubilized receptors are insensitive to divalent cations (Mg2+, Mn2+, Ca 2+) which increase the potency of agonists for particulate receptors. The effects of Mg2+ can be reversed by Gpp(NH)p in particulate preparations; Gpp(NH)p is ineffective for the solubilized preparation. These experiments establish that beta-adrenergic receptors can be solubilized even from crude mammalian membrane preparations. They also show that the mammalian beta-adrenergic receptor in situ is under constraints with respect to agonist affinity and is modulated by divalent cations and guanyl nucleotides in the intact membrane.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 216931     DOI: 10.1007/bf00498810

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  18 in total

Review 1.  In vitro study of beta-adrenergic receptors.

Authors:  B B Wolfe; T K Harden; P B Molinoff
Journal:  Annu Rev Pharmacol Toxicol       Date:  1977       Impact factor: 13.820

2.  Relationship between the beta-adrenergic receptor and adenylate cyclase.

Authors:  E M Ross; M E Maguire; T W Sturgill; R L Biltonen; A G Gilman
Journal:  J Biol Chem       Date:  1977-08-25       Impact factor: 5.157

3.  Hydrodynamic properties of the beta-adrenergic receptor and adenylate cyclase from wild type and varient S49 lymphoma cells.

Authors:  T Haga; K Haga; A G Gilman
Journal:  J Biol Chem       Date:  1977-08-25       Impact factor: 5.157

4.  Magnesium dependence of agonist binding to adenylate cyclase-coupled hormone receptors.

Authors:  L T Williams; D Mullikin; R J Lefkowitz
Journal:  J Biol Chem       Date:  1978-05-10       Impact factor: 5.157

Review 5.  beta-Adrenergic receptor: ligand binding properties and the interaction with adenylyl cyclase.

Authors:  M E Maguire; E M Ross; A G Gilman
Journal:  Adv Cyclic Nucleotide Res       Date:  1977

6.  Agonist-specific alterations in receptor binding affinity associated with solubilization of turkey erythrocyte membrane beta adrenergic receptors.

Authors:  L J Pike; R J Lefkowitz
Journal:  Mol Pharmacol       Date:  1978-03       Impact factor: 4.436

7.  Cation dependence of high-affinity angiotensin II binding to adrenal cortex receptors.

Authors:  H Glossmann; A Baukal; K J Catt
Journal:  Science       Date:  1974-07-19       Impact factor: 47.728

8.  Angiotensin II receptors in bovine adrenal cortex. Modification of angiotensin II binding by guanyl nucleotides.

Authors:  H Glossmann; A Baukal; K J Catt
Journal:  J Biol Chem       Date:  1974-01-25       Impact factor: 5.157

9.  A highly sensitive adenylate cyclase assay.

Authors:  Y Salomon; C Londos; M Rodbell
Journal:  Anal Biochem       Date:  1974-04       Impact factor: 3.365

10.  Beta-Adrenergic receptor interactions. Direct comparison of receptor interaction and biological activity.

Authors:  E M Brown; S A Fedak; C J Woodard; G D Aurbach
Journal:  J Biol Chem       Date:  1976-03-10       Impact factor: 5.157

View more
  10 in total

1.  Alpha noradrenergic receptors in brain membranes: sodium, magnesium and guanyl nucleotides modulate agonist binding.

Authors:  H Glossmann; P Presek
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-01       Impact factor: 3.000

2.  [125I]-HEAT, a selective, high-affinity, high specific activity ligand for alpha 1-adrenoceptors.

Authors:  H Glossmann; F Lübbecke; P Bellemann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-12       Impact factor: 3.000

Review 3.  Biochemical characterization of the beta-adrenergic receptor of the frog erythrocyte.

Authors:  M G Caron; L E Limbird; R J Lefkowitz
Journal:  Mol Cell Biochem       Date:  1979-12-14       Impact factor: 3.396

4.  Relationship between plasma concentrations and cardiac beta-adrenoceptor blockade--a study with oral and intravenous bopindolol.

Authors:  W H Aellig; E Nüesch; G Engel; J Grevel; W Niederberger; J Rosenthaler
Journal:  Br J Clin Pharmacol       Date:  1986-01       Impact factor: 4.335

5.  (+/-)[125Iodo] cyanopindolol, a new ligand for beta-adrenoceptors: identification and quantitation of subclasses of beta-adrenoceptors in guinea pig.

Authors:  G Engel; D Hoyer; R Berthold; H Wagner
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981       Impact factor: 3.000

6.  [125I]-HEAT:fifty percent of the ligand can bind to the alpha1-adrenoceptors with extremely high affinity.

Authors:  H Glossmann; F Lübbecke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-10       Impact factor: 3.000

7.  Alpha adrenoceptors in rat brain: direct identification with prazosin.

Authors:  R Hornung; P Presek; H Glossmann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-09       Impact factor: 3.000

8.  Evidence for an A2 adenosine receptor in guinea pig lung.

Authors:  D Ukena; C G Schirren; K N Klotz; U Schwabe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-10       Impact factor: 3.000

9.  Solubilization and partial purification of putative calcium channels labelled with [3H]-nimodipine.

Authors:  H Glossmann; D R Ferry
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-08       Impact factor: 3.000

10.  Sodium regulation of agonist and antagonist binding to beta-adrenoceptors in intact and Ns-deficient membranes.

Authors:  M Minuth; K H Jakobs
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-06       Impact factor: 3.000

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.